Mesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy
Hector Alvarez, Pamela Leal Rojas, Ken Tye Yong, Hong Ding, Gaixia Xu, Paras N. Prasad, Jean Wang, Marcia Canto, James R. Eshleman, Elizabeth A. Montgomery, Anirban Maitra
Dive into the research topics of 'Mesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy'. Together they form a unique fingerprint.